Vogelbusch optimises important aspect of the bioethanol production from woody raw materials

28-Mar-2008

Vogelbusch GmbH, which is based in Vienna (Austria), announced that it has applied for a patent for an efficient fermentation process for the high-yield extraction of bioethanol from materials containing hemicellulose. Working in partnership with the Institute of biotechnology and Biochemical Engineering at Graz University of Technology, the company has succeeded in extracting significantly more ethanol from this raw material than other processes.

The new process aims to boost the ecological and economic efficiency of bioethanol production from alternative raw materials such as wood waste. Although the extraction of bioethanol from these types of raw materials is, in principle, feasible and offers attractive ecological benefits, current practices have thus far only produced small yields of the desired end product. The development from Vogelbusch GmbH significantly contributes to the cost-efficiency of bioethanol produced from hemicellulose-containing raw materials.

The aim of the research was to optimise the process that converts the carbohydrate xylose into ethanol using the yeast Saccharomyces cerevisiae. Xylose is a key intermediate in the production of bioethanol from wood waste, but production processes based on this material are usually relatively inefficient. The reason for this is the imbalanced availability of the substances NAD and NADP ­ which function as co-enzymes during the conversion process and transfer hydrogen groups ­ in the majority of microorganisms. The optimisation work that Vogelbusch has carried out on S. cerevisiae resolves the issue of co-enzyme imbalance, thereby delivering greater efficiency in the conversion of xylose into ethanol. The following specific adjustments have optimised S. cerevisia:

- Introduction of the capacity to synthesise a form of the enzyme xylose reductase with an altered binding site for certain co-enzymes.

- Introduction of the capacity to synthesise the enzyme xylitol dehydrogenase from Galactocandida mastotermitis.

- Introduction of the capacity to synthesise larger volumes of the enzyme xylulosekinase.

The increased efficiency levels in xylose-based ethanol production thus achieved also help to lower the production of unwanted by-products such as glycerine and xylitol. As a result, this optimised strain of S. cerevisiae is able to produce greater ethanol yields than other previously used strains.

Other news from the department research and development

Most read news

More news from our other portals

So close that even
molecules turn red...

Last viewed contents

Loss of the Y chromosome discovered as a new risk factor for heart disease - Men who lose their Y chromosome in part of their blood cells have an increased risk of cardiovascular disease

Loss of the Y chromosome discovered as a new risk factor for heart disease - Men who lose their Y chromosome in part of their blood cells have an increased risk of cardiovascular disease

Bruker announces acquisition of a spin-off from Ghent University - Acquisition expands nuclear molecular imaging portfolio

Researchers discover way to inhibit major cancer gene

Researchers discover way to inhibit major cancer gene

Swiss biotechnology startup HAYA Therapeutics announces collaboration with Lilly - Discovery of novel regulatory genomic targets for obesity and related metabolic conditions using proprietary RNA platform

Swiss biotechnology startup HAYA Therapeutics announces collaboration with Lilly - Discovery of novel regulatory genomic targets for obesity and related metabolic conditions using proprietary RNA platform

Medigenomix Acquires an Exclusive License for another Genetic Polymorphisms in G-Proteins for Applications in Pharmacogenetics

Breakthrough: Prospect of blood test for Parkinson’s disease for the first time - A new method reliably detects protein changes in blood that are typical of Parkinson's disease: "The results are really sensational"

Breakthrough: Prospect of blood test for Parkinson’s disease for the first time - A new method reliably detects protein changes in blood that are typical of Parkinson's disease: "The results are really sensational"

Evotec and Bayer partner to develop new treatments to fight kidney diseases

Alnylam and PBL Sign Licence Agreement for Baulcombe & Hamilton RNAi patent

Vaccine-induced CD4 T cells have adverse effect in a mouse model of infection - Research offers a 'cautionary tale' for the development of CD4 T cell vaccines

Helix BioPharma Corp. Completes Enrollment in Its Phase II Trial of Topical Interferon Alpha-2b

Merck Plans to Invest € 1 Billion at the Darmstadt Site - Employment guarantee extended until the end of 2025

Merck Plans to Invest € 1 Billion at the Darmstadt Site - Employment guarantee extended until the end of 2025

Agilent Technologies Announces Winner of Third Annual Early Career Professor Award

Agilent Technologies Announces Winner of Third Annual Early Career Professor Award